(Q38592775)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Steliana Ghibu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Catherine Vergely

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Adriana Muresan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

25 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Physiology and Pharmacology

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1021-1027

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

Blood pressure control and nephroprotection in diabetes

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Reversible inhibition of alpha-ketoglutarate dehydrogenase by hydrogen peroxide: glutathionylation and protection of lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Haem oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Direct and indirect antioxidant properties of inducers of cytoprotective proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

21 January 2018

Retinopathy in diabetes

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

An overview of the chemistry and biology of reactive aldehydes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Diabetes and alpha lipoic Acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Flavonoids, vascular function and cardiovascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Heart mitochondria: gates of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Mitochondrial permeability transition and cell death: the role of cyclophilin d

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Hepatic expression and cellular distribution of the glucose transporter family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

21 January 2018

Glutathione synthesis

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Peripheral arterial disease in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Uptake and reduction of alpha-lipoic acid by human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

α-Ketoglutarate dehydrogenase: a mitochondrial redox sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Reactive oxygen species are involved in the stimulation of the mitochondrial permeability transition by dihydrolipoate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Lipid peroxidation: physiological levels and dual biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Alpha-lipoic acid-induced heme oxygenase-1 expression is mediated by nuclear factor erythroid 2-related factor 2 and p38 mitogen-activated protein kinase in human monocytic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Alpha-lipoic acid as a biological antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Molecular aspects of lipoic acid in the prevention of diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Diabetes and foot infection: more than double trouble

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Atrial and vascular oxidative stress in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Carbon monoxide: mechanisms of action and potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Diabetes, oxidative stress and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Alpha-lipoic acid supplementation and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Peroxynitrite reaction with the reduced and the oxidized forms of lipoic acid: new insights into the reaction of peroxynitrite with thiols

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Postischemic myocardial recovery and oxidative stress status of vitamin C deficient rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Evidence that α-lipoic acid inhibits NF-κB activation independent of its antioxidant function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

The mitochondrial permeability transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

The Mitochondrial Permeability Transition Pore is Modulated by Oxidative Agents Through Both Pyridine Nucleotides and Glutathione at Two Separate Sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0353

21 January 2018

Identifiers

DOI

10.1139/CJPP-2014-0353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26406389%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference